The story of a unique molecule in hemophilia A: recombinant single-chain factor VIII.
暂无分享,去创建一个
[1] Stefan Schmidbauer,et al. Physicochemical characterisation of rVIII-SingleChain, a novel recombinant single-chain factor VIII. , 2015, Thrombosis research.
[2] T. Weimer,et al. Non-clinical pharmacokinetics and pharmacodynamics of rVIII-SingleChain, a novel recombinant single-chain factor VIII. , 2014, Thrombosis research.
[3] D. Bensen-Kennedy. Bringing new therapy options to the hemophilia community. , 2013, Thrombosis research.
[4] S. Schulte. Innovative coagulation factors: albumin fusion technology and recombinant single-chain factor VIII. , 2013, Thrombosis research.
[5] J. Mahlangu,et al. Guidelines for the management of hemophilia , 2013, Haemophilia : the official journal of the World Federation of Hemophilia.
[6] P. Fogarty,et al. Biological rationale for new drugs in the bleeding disorders pipeline. , 2011, Hematology. American Society of Hematology. Education Program.
[7] P. Fay. Activation of factor VIII and mechanisms of cofactor action. , 2004, Blood reviews.
[8] P. Hass,et al. Characterization of recombinant human factor VIII. , 1987, The Journal of biological chemistry.
[9] B. Keyt,et al. Structure of human factor VIII , 1984, Nature.